Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
903.55
6.50
(0.72%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma gains on receiving USFDA approval for generic version of Armodafinil Tablets
>>
Natco Pharma informs about press release
>>
Natco Pharma receives USFDA approval for generic version of Armodafinil Tablets
>>
Natco Pharma spurts on receiving USFDA approval for generic version of Budesonide Capsules
>>
Natco Pharma gains on receiving USFDA approval for generic Budesonide Capsules
>>
Natco Pharma receives USFDA approval for generic version of Budesonide Capsules
>>
Natco Pharma informs about press release
>>
Natco Pharma informs about company updates
>>
Natco Pharma invests Rs 120 crore in Visakhapatnam facility: Report
>>
Natco Pharma submits copy of transcript of conference call
<<
<
36
37
38
...52
>
>>